In the case of CXCL14, we have observed differences between control and less-advanced stages (I and II) of CRC, which, as previously mentioned, is an extremely important result considering the fact, that there are no widely available, minimally-invasive methods that would be useful in case of asymptomatic patients (Table 4). The gene discussed is CXCL14; the disease is colorectal carcinoma.